Wash U Awarded $6.5M Grant to Develop Sequencing-Based Breast Cancer Vaccine | GenomeWeb

Researchers at Washington University have received a $6.5 million grant from the Susan G. Komen for the Cure Foundation to develop a personalized, sequencing-based breast cancer vaccine.

William Gillanders, a professor of surgery, and Ted Hansen, a professor of pathology and immunology, will lead the initiative. According to the project abstract, the team will use next-gen sequencing to identify unique tumor antigens, and then incorporate several of those antigens into a vaccine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.